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Introduction 
 
Technological innovation in healthcare is growing at a rapid pace. Developments in 
genetics, stem cell research, bioinformatics, imaging and screening techniques have 
broadened out the arena of health technology. These developments in sophisticated 
technology, it is suggested, have the potential to revolutionize the practices of 
medicine and healthcare by providing more proactive and powerful tools for the 
diagnosis, treatment, and prevention of illness and disease (Liddell et al, 2008; 
Webster, 2002). In support of such claims, available research findings suggest that the 
adoption of new innovative health technologies (IHTs) can result in reducing 
healthcare costs, increasing productivity, healthcare effectiveness, and improving the 
patient’s experience of care by better management of chronic diseases (Liddell et al, 
2008; Healthcare Industries Task Force, 2004).  
 
At the same time, new innovative health technologies present many challenges. 
Evidence indicates that patient safety and proven clinical effectiveness are insufficient 
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to ensure the adoption and implementation of new clinical technologies. The 
prevailing organizational and policy context is crucially important as this may present 
barriers which slow or even prevent uptake (Lehoux 2006). In recent years there has 
been a continuing debate around issues of clinical resistance, organizational/clinical 
restructuring, procurement and commissioning, public trust, and, more widely, around 
the ethical and social implications of techno-scientific innovations in medicine and 
health (Williams and Dickinson, 2008; Webster, 2006; Ferlie et al., 2005). Moreover, 
cost-effectiveness evidence is now required to inform decisions about the funding and 
procurement of new healthcare services and technologies (Fitzgerald et al., 2002). 
Overall, the value of the innovation has to be clearly evident to a number of different 
stakeholders if technologies are to be embedded into actual work practices.  These 
potential barriers have given rise to questions related to the diffusion and adoption of 
emerging medical and healthcare innovations. 
 
This paper examines the dynamics and complexity of innovation adoption processes 
in the context of a rapidly changing healthcare policy landscape. Drawing upon the 
inherently socially negotiated character of meaning, this paper illustrates the 
ambivalent nature of technological innovation by examining the complex ongoing 
interplay of heterogeneous discourses in shaping the adoption of innovative health 
technologies (Law, 1987, 1994). Drawing upon Rye and Kimberly (2007) adoption is 
here understood as a distinct organizational process related to an organization’s 
potential interest in implementing a technological innovation. In so doing, this paper 
draws on the findings of a three year research project which examines the adoption of 
innovative clinical technologies in the UK NHS. In particular, we explore the nature, 
role and dynamics of heterogeneous discourses (technological, 
managerial/professional, clinical), in shaping the adoption of a retinal imaging 
technology in a UK hospital Trust. In this regard, we contribute to the development of 
alternative ways of describing, analysing, and theorizing the process of technological 
innovation in healthcare.  
 
The Context of Study 
 
In the UK, promoting the adoption of technological innovation in healthcare systems 
is a key element of government policy to increase productivity and clinical service 
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quality within the NHS (Robert et al., 2010; Liddell et al., 2008; Greenhalgh et al., 
2005). However, it is generally acknowledged that technology adoption within the 
NHS is slow and uncoordinated (Darzi, 2008; Cooksey, 2006). The Healthcare 
Industries Task Force (2004), for example, described the NHS as ‘a late and slow 
adopter of technology’ and addressed the need for a coherent approach to the adoption 
of technological innovation. In response, to this and other challenges, a number of 
policies have been developed aiming to facilitate innovation by emphasising both the 
importance of technology and the role that technology can play in improving patient 
safety, health outcomes and increasing productivity (Department of Health, 2007). 
For example, current policy initiatives towards evidence-based medicine (EBM) aim 
to promote the adoption of innovations of proven value in all areas of clinical 
practice. Furthermore, various national bodies and agencies with a technology remit 
have been established, such as the NHS National Innovation Centre (NIC) and the 
NHS Technology Adoption Centre (NTAC) whose aims include encouraging, 
promoting and accelerating the uptake of new technological innovations (Liddell et al, 
2008).  
 
Technological Innovation in Healthcare 
 
A large and growing body of literature has explored the role and nature of 
technological innovation in healthcare (Robert et al., 2010; Faulkner, 2009; Williams 
and Dickinson, 2008; Rye and Kimberly 2007; Webster, 2006; Ferlie et al., 2005; 
Greenhalgh et al., 2005; 2004; Fleuren, Wiefferink, and Paulussen, 2004; Walker, 
2003; Wolfe, 1994; Scott 1990; Greer 1977). Theory addressing the diffusion and 
adoption of technological innovation has traditionally focused on the techno-
economic properties and features of innovation (i.e. technological capabilities, size or 
features of the organizational structure, readiness, resources etc) as well as on the 
social context of the innovation process by exploring the contingencies and socio-
political particularities surrounding innovation (i.e. individual traits and 
organizational factors such as individual leadership, culture etc). Although these 
studies have contributed towards the wider analysis of the innovation process, often 
implicitly and/or explicitly they assume a clear demarcation between functional forms 
of analysis or techno-centric perspectives advanced, for example, by economics, and 
engineering accounts and more critical or sociological approaches which emphasize 
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the political nature and the social ramifications of the innovation process. Drawing 
upon a distinct theoretical and methodological foundation each approach offers 
contrasting explanations about the nature, role and influence of technological 
innovation. 
 
Techno-centric or deterministic studies view the diffusion and adoption of 
technological innovation as the outcome of a rational-linear process (i.e. an essentially 
autonomous) with inevitable determining impacts or effects on the 
organizations/socio-economic life and society as a whole (MacKenzie, 1999; 
MacKenzie and Wajcman, 1985; Williams and Edge, 1996). Traditional ‘linear 
models’/staged or sequential models have tended to emphasise the ‘structural 
properties’ of innovation where organizational level variables (i.e. structural 
determinants such as size or features of the organizational structure) and technological 
capabilities and capacities are considered as the main enabler of change (Williams et 
al., 2005).  At the centre of these explanations lies a ‘casual technicism’ (Grint and 
Woolgar, 1997), a reductionist approach to innovation which assumes an unilinear 
technological impact. As such, they assume that technology is an exogenous and 
relatively autonomous driver of social and organisational change with predetermined 
impacts on various social and organisational outcomes, such as governance structures, 
work routines, productivity and performance (Edge, 1988).  
 
Viewing technological innovation as a rational-linear process has been the subject of 
many criticisms (Williams and Edge, 1996; McLoughlin, 1999).  Overall, it has been 
argued that the causal simplicity offered by such a perspective fails to acknowledge 
the complexity of institutional, political, and social factors that shape the diffusion 
and adoption of innovation. Alternatives to techno-centric, linear models emphasize 
the profound uncertainties surrounding technological innovation, by highlighting the 
non-rational nature of decision-making and the political context within which 
innovations become adopted and used (i.e. non-structural determinants such as the 
micro-politics of the organisational setting, interests, prevalent rhetorics, fads, 
individual leadership, culture) (Grint and Woolgar, 1997; Neyland and Woolgar, 
2002). These approaches are more participative in nature highlighting the complexity, 
political context, broader social network and the social ramifications of the innovation 
process (Dawson and Buchanan, 2005; Knights and Murray, 1994).  This position 
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implies that the trajectory of innovation does not reflect its technical advantage in 
terms of any inherent capabilities and characteristics, but rather the social processes 
which establish consensus around its superiority (McLoughlin, 1999).    
 
While sympathetic to the critical view of innovation, it is suggested that, empirical 
evidence on the diffusion/adoption of innovation has generally been reduced to a 
single level of analysis (functional vs sociological explanations); and has also 
assumed simple causal relationships between variables (Anderson et al., 2004) when 
it seems that technological innovation is subject to powerful, albeit complex 
discourses. As such they have failed to address the important interactions between 
different levels of analysis (for example addressing the impacts of both techno-
economic properties and organizational context on innovation adoptions within 
strategic decision-making contexts) and thus failed to take into account the 
interrelationship between these two positions. 
 
Innovation as Discourse 
 
Alignment of heterogeneous discourses is a key element of successful innovation 
neglected by simple linear models of technological imperative and market demand 
(Williams et al., 2005; Suchman, 2000; Latour, 1999; Law, 1992; Callon, 1986). In so 
doing, it examines the complexity surrounding technological innovation by exploring 
the nature, role and dynamics of heterogeneous discourses in the framing and 
constitution of adoption pathways. For the purposes of this paper, discourse is 
conceived as the performative act that systematically produces and structures a 
particular order/representation of reality (Berger and Luckman, 1966; Gergen, 1999).  
as systems of representation, discourses regulate/structure the meanings which can 
and cannot be produced through both language and practice. In so doing, they provide 
the context in which phenomena become negotiated and enacted. The notion of 
discourse refers not just to linguistic forms of communication and representation but 
to a variety of textual forms such as narratives, documents, artwork, symbols, 
technologies, architectures and other artefacts (e.g. Fairclough, 1995; Grant et al., 
1998; Taylor et al., 1996; Wood and Kroger, 2000).  By the same token technological 
innovation is framed as a social system/process that encompasses a broad range of 
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textual forms/phenomena including material objects, knowledge practices, learning, 
interests, power, politics, leadership and conflict resolution (Bowker and Star, 1999). 
 
Drawing upon these ideas, the diffusion and adoption of technological innovation is 
considered as the outcome of the ongoing negotiation between sociomaterial 
discourses in practice (Latour, 2005, 1993). Rather than residing within the techno-
economic features of innovation or the micro-politics of the organization and the 
commitments of the various actors involved, the sustained acceptability and adoption 
of technological innovation rests on a series of alliances or associations across 
sociomaterial discourses that must be assembled together in the social network 
(Latour 1993; Law, 1987, 1994; Callon, 1986).  The idea of alignment and 
‘negotiation’ of interests stresses therefore technological innovation as a contingent 
process. Challenging traditional ‘linear’ models this paper suggests that sociomaterial 
alliances or associations represent a defining characteristic in the innovation process 
by enabling or constraining particular adoption pathways. As different ‘relevant social 
groups’ have a diverse set of interests, stability and social order rests crucially on the 
ability to translate, that is, the re-presentation/re-framing of meaning, ideas or 
practices in action (Callon, 1991). Accordingly, when a form of consensus around 
multiple meanings emerges, an innovation may become stabilized (Pinch and Bijker, 
1984). When this occurs, the outcome is intended to be an occasion where the 
discourse is not just technological but involves the consideration of the ethical, 
organizational, professional, social and cultural aspects of the innovation. Thus, 
success always depends upon overcoming resistance and enrolling allies to what can 
be an ever-shifting support network of sociomaterial relations and discourses. 
 
This position does not presuppose a prior distinction between the social and the 
material domains of discourse. In other words, the social and material domains are not 
considered a priori as self-contained entities that influence each other the adoption of 
innovation (Orlikowski and Scott 2008). Instead, discursive and material relations are 
entwined in a mutual shaping process (McLoughlin and Dawson, 2003; Pickering 
1995).  The mutual shaping perspective provides the basis for reconsidering the 
supposed ontological separation among the social and the material, the subject and the 
object influencing the trajectory of technological innovation (Barad, 2007). At the 
same time, this perspective supports the interpretive flexibility of technological 
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innovation beyond the design phase, and the scope for innovation through re-
interpretation and re-configuration to support and challenge vested interests, 
identities, and power positions (McLoughlin, 1999). These wider cultures of 
ambiguity are of central importance in understanding the context within which 
innovative health technologies are deployed. 
 
Methodology 
 
Drawing on ethnographic fieldwork, this paper explores the ongoing negotiation and 
translation of heterogeneous discourses between different groups and individuals in an 
attempt to introduce a new retinal imaging technology in a UK hospital Trust. This 
paper is based on fieldwork that was conducted during 2009-2010. Detailed data 
collection was conducted through semi-structured interviews (14 in total) 
supplemented by participant observation, and review of the Trust’s internal 
documents and policies related to technology adoption. Participants included 
clinicians, chief executives, procurement managers and commissioners, to project 
managers, technology providers and other specialists. All interviews lasted between 
60-90 minutes and were digitally recorded and transcribed. For confidentiality reasons 
all parties collaborating in the research have been anonymised. 
 
Background 
 
The technologies under study were identified by the NHS National Technology 
Adoption Centre (NTAC) in its 2008 National Call for projects. NTAC aims to 
increase the adoption of technological innovation within the NHS; in particular 
technology that has been indentified as having the potential to deliver significant 
benefits to the NHS system and particularly to its patients. It functions as an advisory 
body on policy to the UK government, promoting and supporting the uptake of 
technologies which have been successfully selected as standard of care in its 
Technology Implementation Projects. NTAC is also responsible for creating meeting 
places for actors involved in the innovation process. The overall aim is the production 
of guidelines (How-to-Why-to Guides) detailing how a technological innovation can 
be successfully implemented and the benefits to both patients and organisations that 
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can be achieved. The Department of Health and the National Institute of Health 
Research are the most important contributors to its budget. 
 
In 2008 NTAC announced a call for technologies for its Technology Implementation 
Projects and after closer assessment a new ultra wide-field retinal imaging technology 
(henceforth, WRIT) was selected. The application was submitted by Ophtamol Plc for 
its technology which was perceived unique in providing a wide digital image of the 
retina. The technology provides, in less than a second, a 200 degree digital image of 
the retina by means of a scanning laser system placed close to the eye. The digital 
image is expected to highlight pathology on the retina to the quality required by an 
ophthalmologist to make a diagnosis. Following the selection of technology, NTAC 
initiated a Call for Trusts to invite applications from Trusts to work on 
implementation projects related to the adoption of WRIT. The research site 
(henceforth, NHS Foundation Trust) made a successful application to NTAC’s call for 
support in implementing WRIT. The Trust provides ophthalmic services to two 
districts (total population 500,000), allowing testing of a wide range of adoption 
scenarios.  
 
Main Findings 
  
The NHS Foundation Trust described in its application how retinal imaging was an 
area of growing interest for the Trust. The Trust was considered to be ‘progressive’ 
towards change and had developed a programme of service improvement which 
aimed to promote the adoption of technological innovation to healthcare efficiency 
and effectiveness. As the Executive Director for Business Development in the Trust 
explained: 
 
‘ …As part of our strategic direction in the future, we wish to develop our research 
and development approach and we also want to develop our approach to technology 
adoption, innovation adoption…Well, l think that as an organisation we are pretty 
good at developing a business case and relating to new technology and deciding to 
adopt it if it washes it’s face if it makes sense if it raises our returns on our 
investment…I think that side of this is actually very good, but in terms of the input to 
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that, it’s pretty much purely driven by the clinicians who may or may not be interested 
in using this area to advance their clinical care…’  
 
The Trust generally had a good relationship and understanding with its PCT. The 
Chief of Business Development at the Trust had obtained a commitment from the 
PCT to provide financial support in the procurement of the technology in order to 
evaluate its utility, especially with a view to determining if a part of the examination 
process could be moved out into the community. In this context, hosting an NHS 
adoption project was therefore perceived to be a natural complement to the Trust’s 
programme. During a discussion about the Trust’s initial interest in adopting WRIT, a 
senior project manager in NTAC explained: 
 
‘…It’s an ideal scenario because they already had – with hindsight obviously we 
know this – and they already had a really excellent working relationship with their 
PCT in terms of – specifically in terms of adopting new technology, new innovative 
technology.  And the WRIT product, the optimum product is highly innovative.  They 
already had the – an understanding, the support, and particularly an understanding 
of financial support from the PCT for the project.  So ideal situation; the trust already 
has earmarked funding to procure this technology…’ 
 
The Trust had also recently become a research partner in two large scale technology 
integrating EU projects. Moreover, the ophthalmology department had recently 
appointed a new retinal specialist who aimed to be one of the pioneers in the adoption 
of WRIT. This made the Trust an ‘ideal’ site for the adoption of the WRIT. As a 
senior project manager explained: 
 
‘And I got that impression when I did the due diligence interview with him, and 
involved with him was the lead Ophthalmologist who would in fact have been the 
clinical lead for the project had it gone ahead then.  He’d had previous contact with 
the technology; he knew about it, he knew what you could do with it, he knew what the 
technology promised.  So really excellent set up in terms of financial support, in terms 
of clinical support, in terms of organisational support.  Organisational support 
coming from M.P and clinical support, Ophthalmologist; the financial support, 
PCT…  All bases covered…’ 
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In this context, the potential enrolment of the clinical, organizational, managerial and 
financial support network from both the PCT and the Trust was perceived as a key 
enabler for the adoption of WRIT. From a clinical perspective, the technology 
claimed that it could replace the current practice of diagnosis by direct visual 
examination of the retina after dilating the pupil. It was expected to provide a much 
faster detection of pathology, by removing the need for a lengthy pupil dilation 
process prior to examination, allowing for a better patient experience and shortening 
the examination period itself. As such, it was claimed that the adoption of WRIT 
could result in enhanced patient benefit (through earlier intervention, particularly for 
peripheral pathologies) and reduced waiting times. The potential clinical capabilities 
of WRIT were expressed as follows in the application submitted by the Trust to 
NTAC: 
  
‘Reduced waiting times by elimination of the pupil dilation stage in the pathway 
where appropriate…Improvements in diagnostic capability through high definition 
imaging being made routinely to all relevent patients…200 degree imaging will 
enable peripheral retinal abnormalities to be identified at the earliest possible 
stages…This will allow improved prognosis through application of curative or 
disease modifying technology at the optimal stage of disease progression…’ 
 
From an organizational perspective, the adoption of WRIT was translated in terms of 
improving patient throughput performance and reducing unnecessary referrals. Thus 
the adoption of WRIT was presented as an opportunity for the Trust to improve 
patient care in terms of effectiveness and efficiency. During a conversation about its 
potential benefits the producer of WRIT commented: 
 
‘Bigger opportunity to treat, more patients, still a huge amount of unnecessary 
referral and the pretty archaic way patients are managed once they arrive in the 
clinic.  And imaging, whether it’s our imaging or anything else could play a huge role 
in improving patient management, documentation, improving the standard of care 
patients get, improving the speed in which they get through an Ophthalmic clinic.  
The patient can be in the clinic all day, the doctor probably only sees them three times 
for thirty seconds. A lot of the tests, particularly ours and some others, really could 
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easily be captured in the initial waiting period so that data would all be up on the 
screen, in the consulting room’ 
 
It was also claimed that it could be possible for the imaging itself to be carried out by 
an imaging specialist in primary care, rather than an ophthalmologist in secondary 
care, creating the possibility of pathway redesign. The lead clinician was keen to cut 
unnecessary referrals from primary care in order to optimise use of clinicians’ time 
and to increase throughput of patients with a genuine need to see a consultant at 
secondary care. The potential for service redesign through technology adoption was 
highlighted in a ‘due diligence’ report produced by NTAC to evaluate the Trust’s 
application, placing technology at the center of change to current practice. 
 
‘Retinal imaging is an important tool for the screening and diagnosis of eye 
problems, such as retinal detachment, glaucoma, cataracts, retinal holes/retinal tears 
and age-related macular degeneration…this technology could be used in either 
primary care or secondary care and can prevent a high degree of false positive 
referrals [to secondary care]’   
 
As the above comments illustrate, a central element of the clinical capabilities of 
WRIT was a potential improvement of clinical performance together with a 
redirection of resources from secondary to primary care (i.e. service redesign). 
Although the Trust was already aware of the potential benefits claimed for the new 
technology, there was still no consensus among the clinicians as to whether or not the 
technology could add much value to existing clinical practice by replacing the current 
pathway. Following a period of onsite visits and a presentation of WRIT in the 
department, uncertainty was raised among the clinicians around the clinical efficacy, 
the overall cost of technology and the quality of the image required to provide sound 
diagnosis. In particular, some clinicians expressed the view that the technology did 
not provide an opportunity for service process improvement and the related costs were 
so high that it was far cheaper to simply replace their existing fluorescein angiography 
camera. During a discussion about the clinicians concerns, a lead consultant 
commented: 
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‘…I mean, we saw the pictures and they said what are the advantages, that gives a 
wider view and a clear picture.  But I think people felt that it is more like what we can 
see with the indirect ophthalmoscope, like how we examine patients, and the specifics 
we can gain from the technology are already available from other technologies like 
OCT for example…And I think the main opinion at that time was that it is not needed, 
it doesn't say it’s a bad technology but it’s not needed because we have already 
means, all the means that we need.  So we don't need this extra technology because of 
the cost involved of course of introducing new technologies…’ 
 
These concerns of clinicians over the clinical efficacy of WRIT led the Trust to 
question its initial interest in adopting the technology. In so doing, issues related to 
investment and staff training and re-configuration of clinical practices started to 
emerge in the Trust. 
 
 ‘So, you know, as I said, it’s a nice thing but do we really need it?  Do we really need 
to buy it?  And also when you buy something like that you need to train people to use 
it, to interpret it.  And it’s a lot of not only just to buy something, it takes a lot of time 
and effort for the department to integrate it into the medical practise.  So it’s not easy 
to introduce something unless it’s really necessary.’  
 
Moreover, notes of a meeting between the Trust and NTAC revealed that the potential 
of reducing unnecessary referrals to secondary care, whilst benefitting the local health 
economy, could result in a loss of income to the Trust. Essentially the risk of loss of 
income depended upon the uncertainty attached to whether the loss of income due to 
avoiding false positives would be compensated by the gain in income of reducing 
false negatives. Moreover, reducing unnecessary referrals would create further risks 
and uncertainties, as new ‘filtering’ services in secondary care and education work 
across the primary/secondary care interface would both be required.   
 
‘The lead clinician is keen to cut unnecessary referrals from primary care in order to 
optimise use of clinicians’ time and to increase throughput of patients with a genuine 
need to see a consultant at secondary care. [WRIT] would be used in secondary care 
to provide a second level of filter (using technician staff rather than doctors) at the 
point of entry in the secondary care pathway. He is also keen to deploy …[WRIT] in 
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primary care (optometrists) as the first line of filtering/detection (with 
training/support being provided by visiting secondary care consultants)…The lead 
clinician believes that the deployment of [WRIT] in care pathways would, because of 
the upstream filtering that it provides, actually result in the identification of a greater 
number of people requiring secondary care. Consequently, he would not expect to see 
a reduction in Trust income from deploying [WRIT], conversely to some beliefs.’ 
 
From a clinical perspective, doubts were raised with relation to the examination of the 
retina without dilation of pupils. It was claimed that for the majority of patients seen 
within the Trust, a clear view of the central part of the retina (the macular area) is 
essential and the technology did not offer this option. 
 
‘Dilating the pupil is not a big deal I think for medical retinal practise.  Because most 
of the patients will need dilatation anyway to have a look at the back of the eyes... 
most of the retinal pathology is at the back, at what we call the fundus or the central 
part of the retina, the macular area…You cannot examine the back of the eye properly 
without dilatation....So, you know, if we have other technologies which need dilatation 
we will not abandon it for this technology, just because of the lack of need for the 
dilatation’ 
 
Further, it was suggested that peer-reviewed evidence was required to demonstrate the 
clinical value of WRIT. As a clinician in the Trust explained: 
 
‘Well, we are secondary care, this is what I’m saying.  Maybe tertiary care, in some 
tertiary care centres if they would like to promote something like that they should get 
first university hospitals to get it.  And then they will do some research and if they can 
show it could be of value and publish papers to show that this was necessary to 
advance our medical practice and management of patients, then we can probably 
propagate it to other hospitals.  But at the moment, it doesn't feature much in the 
research to show its value…’ 
 
Overall, there was considerable doubt about WRIT amongst the ophthalmologists and 
the Trust determined that the technology did not live up to the promise of replacing 
conventional methods of clinical practice. Therefore, despite the expectations and 
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promises of WRIT and its potential benefits for both patients and clinical practice, the 
outcome as set out in an early close-down report prepared by NTAC, was as follows. 
 
‘The feedback …is that they [the Trust] do not consider it viable, medically or 
operationally, to replace current practice with [WRIT]. The natural place for the 
technology, as currently exhibited by a unique product, is considered to be high street 
optical services…Therefore, the project is to be closed down.’ 
 
Concluding Remarks 
 
The view of innovation as the outcome of sociomaterial alliances or associations 
stresses the complex and ambiguous nature of technological innovation, often seen as 
the assembly of diverse and shifting discourses/representations (Callon, 1991). These 
heterogeneous discourses that accompany the attempted diffusion of innovation have 
the potential to create change or enact new organizational realities (Clegg et al., 
2006). On the other hand, they also play a crucial role in the ‘negotiability’ of 
uncertainty and risk of such innovations. Indeed, much of the negotiability of new 
technological innovations depends on masking such uncertainty and mobilizing a 
range of claims about the capabilities and future trajectory of innovation (Borup et al., 
2006; Brown and Michael, 2003). 
 
Drawing upon these ideas, this paper attempted to illustrate the negotiability of 
technological innovation, by exploring the various heterogeneous discourses that 
entered into the ultimately failed adoption of a retinal imaging technology within a 
UK hospital Trust. In the context of this study, the emerging tensions between the 
need to provide clinical and cost-effectiveness evidence for the adoption of WRIT and 
to manage the inherent uncertainty, resulted in the early termination of the retinal 
imaging project.. In particular, uncertainties attached to the clinical benefits, the use 
of the technology, the potential loss of income to the Trust and work involved across 
the primary/secondary care interface, resulted in the lack of alignment of actors’ 
interests, thus negatively affecting adoption. 
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